Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (61-70 of 539) with videos related to

Pageof 54
Sort By:
Bone|July 24, 2023
Identification of focal lesion characteristics in MRI which indicate presence of corresponding osteolytic lesion in CT in patients with multiple myelomaNina Hildenbrand, André Klein, Klaus Maier-Hein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Dose-dependent effect of thalidomide on overall survival in relapsed multiple myelomaKai Neben, Thomas Moehler, Axel Benner, et al.
Journal of the Neurological Sciences|March 31, 2004
Single-cell PCR analysis of the immunoglobulin heavy-chain CDR3 region for the diagnosis of leptomeningeal involvement of B-cell malignancies using standard cerebrospinal fluid cytospinsAndreas Hug, Brigitte Storch-Hagenlocher, Juergen Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Effect of acupuncture compared with placebo-acupuncture at P6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trialKonrad Streitberger, Mireen Friedrich-Rust, Hubert Bardenheuer, et al.
Annals of Hematology|November 20, 2003
Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomideMathias Witzens, Thomas Moehler, Kai Neben, et al.
Haematologica|February 9, 2018
Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levelsPankaj Yadav, Maximilian Merz, Elias K Mai, et al.
Haematologica|April 16, 2013
Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myelomaMatthieu Schoenhals, Alboukadel Kassambara, Jean-Luc Veyrune, et al.
Annals of Hematology|April 15, 2017
Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional surveyMaximilian Merz, Lenka Kellermann, Wolfram Poenisch, et al.
Haematologica|March 31, 2015
Efficacy of single versus boost vaccination against influenza virus in patients with multiple myelomaMichael Hahn, Paul Schnitzler, Brunhilde Schweiger, et al.
Haematologica|March 17, 2004
Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trialAxel Glasmacher, Hartmut Goldschmidt, Jörg Mezger, et al.
Pageof 54

Showing results (61-70 of 539) with videos related to

Sort By:
Pageof 54
Bone|July 24, 2023
Identification of focal lesion characteristics in MRI which indicate presence of corresponding osteolytic lesion in CT in patients with multiple myelomaNina Hildenbrand, André Klein, Klaus Maier-Hein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Dose-dependent effect of thalidomide on overall survival in relapsed multiple myelomaKai Neben, Thomas Moehler, Axel Benner, et al.
Journal of the Neurological Sciences|March 31, 2004
Single-cell PCR analysis of the immunoglobulin heavy-chain CDR3 region for the diagnosis of leptomeningeal involvement of B-cell malignancies using standard cerebrospinal fluid cytospinsAndreas Hug, Brigitte Storch-Hagenlocher, Juergen Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Effect of acupuncture compared with placebo-acupuncture at P6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trialKonrad Streitberger, Mireen Friedrich-Rust, Hubert Bardenheuer, et al.
Annals of Hematology|November 20, 2003
Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomideMathias Witzens, Thomas Moehler, Kai Neben, et al.
Haematologica|February 9, 2018
Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levelsPankaj Yadav, Maximilian Merz, Elias K Mai, et al.
Haematologica|April 16, 2013
Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myelomaMatthieu Schoenhals, Alboukadel Kassambara, Jean-Luc Veyrune, et al.
Annals of Hematology|April 15, 2017
Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional surveyMaximilian Merz, Lenka Kellermann, Wolfram Poenisch, et al.
Haematologica|March 31, 2015
Efficacy of single versus boost vaccination against influenza virus in patients with multiple myelomaMichael Hahn, Paul Schnitzler, Brunhilde Schweiger, et al.
Haematologica|March 17, 2004
Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trialAxel Glasmacher, Hartmut Goldschmidt, Jörg Mezger, et al.
Pageof 54